EVALUATION OF ULTRASOUND REMISSION CRITERIA IN PATIENTS WITH RHEUMATOID ARTHRITIS DURING TOCILIZUMAB THERAPY

EVALUATION OF ULTRASOUND REMISSION CRITERIA IN PATIENTS WITH RHEUMATOID ARTHRITIS DURING TOCILIZUMAB THERAPY

Objective: to study the association of ultrasound (US) remission criteria with the clinical and laboratory indicators of inflammatory activity, functional status, and X-ray changes in patients with rheumatoid arthritis (RA) during tocilizumab (TCZ) therapy.Subjects and methods. The trial included 36...

Full description

Bibliographic Details
Main Authors:	Rita Aleksandrovna Osipyants, D E Karateev, E Yu Panasyuk, G V Lukina, A V Smirnov, S I Glukhova, E N Aleksandrova, A V Volkov, E L Nasonov
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2013-12-01
Series:	Научно-практическая ревматология
Subjects:	rheumatoid arthritis remission joint ultrasonography subclinical synovitis x-ray destruction progression tocilizumab
Online Access:	https://rsp.mediar-press.net/rsp/article/view/1335

Similar Items

Value of ultrasound indices for the assessment of rheumatoid arthritis activity and tocilizumab therapy efficiency
by: Rita Aleksandrovna Osipyants, et al.
Published: (2013-11-01)

EVALUATION OF THE EFFICIENCY OF TOCILIZUMAB THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS BY ULTRASOUND AND X-RAY DATA
by: Rita Aleksandrovna Osipyants, et al.
Published: (2013-02-01)

Evaluation of the clinical efficiency of tocilizumab versus rituximab therapy in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-08-01)

Significance of arthrosonography in the diagnosis of metatarsophalangeal joint injury in patients with rheumatoid arthritis
by: Rita Aleksandrovna Osipyants, et al.
Published: (2013-06-01)

Evaluation of the clinical efficiency of tocilizumab therapy, by using DAS 28, SDAI, CDAI indices and new 2011 EULAR/ACR remission criteria in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-04-01)

RAPID EFFECT OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS
by: E Yu Panasyuk, et al.
Published: (2011-08-01)

Evaluation of the structural changes of the hand joints and the rates of rheumatoid arthritis progression according to ultrasound data
by: Rita Aleksandrovna Osipyants, et al.
Published: (2013-04-01)

Experience with tocilizumab in patients with rheumatoid arthritis (according to the data of the LORNET multicenter trial)
by: E Yu Panasyuk, et al.
Published: (2013-04-01)

Clinical, Imaging, and Pathological Suppression of Synovitis in Rheumatoid Arthritis: Is the Disease Curable?
by: Serena Bugatti, et al.
Published: (2018-05-01)

Successful long-term remission through tapering tocilizumab infusions: a single-center prospective study
by: Chayma Ladhari, et al.
Published: (2020-02-01)

Ultrasound remission in patients with rheumatoid arthritis in clinical remission
by: Rym Fakhfakh, et al.
Published: (2021-12-01)

Impact of tocilizumab therapy on fatigue in patients with rheumatoid arthritis
by: Anna Sergeyevna Starkova, et al.
Published: (2012-06-01)

Serum levels of reactive oxygen metabolites at 12 weeks during tocilizumab therapy are predictive of 52 weeks-disease activity score-remission in patients with rheumatoid arthritis
by: Arata Nakajima, et al.
Published: (2019-12-01)

Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biology
by: Xavier M Teitsma, et al.
Published: (2018-10-01)

FUNCTIONAL ABILITY AND QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TOCILIZUMAB THERAPY
by: Anna Sergeyevna Starkova, et al.
Published: (2014-02-01)

IMPACT OF TOCILIZUMAB THERAPY ON STRUCTURAL JOINT DAMAGE PROGRESSION IN RHEUMATOID ARTHRITIS
by: Anastasia Sergeevna Avdeeva, et al.
Published: (2012-10-01)

Association of genetic markers with the efficiency of tocilizumab treatment for rheumatoid arthritis
by: Irina Anatolyevna Guseva, et al.
Published: (2013-11-01)

Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation
by: E. V. Udachkina, et al.
Published: (2015-11-01)

Ultrasonographic findings of rheumatoid arthritis patients who are in clinical remission
by: Hadi Karimzadeh, et al.
Published: (2018-01-01)

New approaches to pharmacotherapy for rheumatoid arthritis: perspective for use of tocilizumab (monoclonal antibodies to interleukin-6 receptor)
by: Evgeniy L'vovich Nasonov, et al.
Published: (2010-05-01)

The efficiency and safety of tocilizumab in rheumatoid arthritis(intermediate results of a Russian multicenter study)
by: E L Nasonov, et al.
Published: (2010-04-01)

Dynamic Contrast-Enhanced MRI Confirms Rapid And Sustained Improvement Of Rheumatoid Arthritis Induced By Tocilizumab Treatment: An Italian Multicentre Study
by: Cimmino MA, et al.
Published: (2020-02-01)

LONG-TERM SAFETY AND EFFICACY OF TOCILIZUMAB IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS OF MODERATE OR HIGH ACTIVITY (RESULTS OF PHASE III MULTICENTER EXTENSION CLINICAL STUDY ML28124)
by: E. L. Nasonov, et al.
Published: (2018-07-01)

RHEUMATOID ARTHRITIS: THE PROBLEMS OF REMISSION AND THERAPY RESISTANCE
by: E. L. Nasonov, et al.
Published: (2018-07-01)

Agreement of clinical examination and ultrasound methods for detection of joints involvements in rheumatoid arthritis
by: Hadi Karimzadeh, et al.
Published: (2017-01-01)

Ultrasound in rheumatoid arthritis - volar versus dorsal synovitis evaluation and scoring
by: Constantinescu C, et al.
Published: (2011-06-01)

The MCP2 and the wrist plus two extensor compartments are the most affected and responsive joints/tendons out of the US7 score in patients with rheumatoid arthritis-an observational study
by: A. F. Podewski, et al.
Published: (2022-08-01)

Identification of differential co-expressed gene networks in early rheumatoid arthritis achieving sustained drug-free remission after treatment with a tocilizumab-based or methotrexate-based strategy
by: Xavier M. Teitsma, et al.
Published: (2017-07-01)

USE OF THE NEW GENETIC ENGINEERING BIOLOGICAL AGENT TOCILIZUMABIN THE TREATMENT OF RHEUMATOID ARTHRITIS
by: E L Nasonov, et al.
Published: (2010-03-01)

USE OF THE NEW GENETIC ENGINEERING BIOLOGICAL AGENT TOCILIZUMABIN THE TREATMENT OF RHEUMATOID ARTHRITIS
by: E L Nasonov, et al.
Published: (2010-03-01)

How should a patient with rheumatoid arthritis behave after achievement of remission?
by: D. E. Karateev
Published: (2016-03-01)

TIME COURSE OF CHANGES IN LABORATORY BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS DURING TOCILIZUMAB THERAPY
by: E N Aleksandrova, et al.
Published: (2011-06-01)

Efficacy and safety of tocilizumab in Korean patients with active rheumatoid arthritis
by: Han Joo Baek, et al.
Published: (2019-07-01)

ADALIMUMAB DISCONTINUATION IN PATIENTS WITH RHEUMATOID ARTHRITIS AFTER ACHIEVING SUSTAINED REMISSION
by: N. V. Demidova, et al.
Published: (2018-07-01)

The changing role of ultrasonography examination in patients with rheumatoid arthritis in light of recent studies
by: Marta Dura, et al.
Published: (2020-06-01)

Optical imaging (HandScan) can identify ultrasound remission in rheumatoid arthritis
by: Charline Rinkin, et al.
Published: (2024-05-01)

PREDICTION OF TOCILIZUMAB AND RITUXIMAB EFFECTIVENESS IN RHEUMATOID ARTHRITIS
by: Volkava M. V.
Published: (2019-11-01)

The initial ultrasonographic examination of hands and feet joints in patients with early rheumatoid arthritis
by: Monika Ponikowska, et al.
Published: (2015-09-01)

Synovial membrane in early rheumatoid arthritis: clinicomorphological comparisons
by: D E Karateev, et al.
Published: (2003-05-01)

Impact of tocilizumab therapy on immunological parameters in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-06-01)